Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase III, Randomized, Open-label, Active-controlled, Multicenter Trial to Study the Contraceptive Efficacy and Safety of the Commercial Batch of Oral Tablets of MK-8175A (Nomegestrol Acetate - 17beta-estradiol) in Healthy, Sexually-active Women Aged 18-50 Years

Next Previous
X
Search
Trial Profile

A Phase III, Randomized, Open-label, Active-controlled, Multicenter Trial to Study the Contraceptive Efficacy and Safety of the Commercial Batch of Oral Tablets of MK-8175A (Nomegestrol Acetate - 17beta-estradiol) in Healthy, Sexually-active Women Aged 18-50 Years

Status: Discontinued
Phase of Trial: Phase III

Latest Information Update: 05 May 2022

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Estradiol/nomegestrol (Primary) ; Ethinylestradiol; Ethinylestradiol/norethisterone; Ferrous fumarate
  • Indications Pregnancy
  • Focus Registrational; Therapeutic Use
  • Sponsors Merck & Co; Organon

    • Most Recent Events

    • 03 Dec 2014 Status changed from completed to discontinued, as reported by ClinicalTrials.gov record.
    • 20 Feb 2014 According to ClinicalTrials.gov record, status changed from active, no longer recruiting to completed.
    • 24 Apr 2013 Planned End Date changed from 1 May 2014 to 1 Jun 2014 as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top